Skip to main content

Find Clinical Trials

Home
Conditions
Thymoma

Clinical trial condition

Thymoma

Explore clinical trials studying Thymoma. Study availability and eligibility vary by location and protocol.

90 public trials 22 recruiting studies

Refine in advanced search Browse all conditions

Thymoma trial results

Completed

Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors

NCT03102320

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +28 more
Locations: Mayo Clinic Hospital Phoenix, Arizona, United States

University of Southern California Los Angeles, California, United States

Stanford Health Care Stanford, California, United States

MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States

View all 72 locations

View Trial Details

Completed

Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors

NCT03023319

Conditions: Adenoma, Adnexal Diseases, Bladder Cancer, +44 more
Locations: Augusta University Georgia Cancer Center Augusta, Georgia, United States

View Trial Details

Completed

A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas

NCT02220855

Conditions: Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +6 more
Locations: Indiana University Simon Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

Prognostic Factors in Patients Submitted to Surgical Treatment for Thymoma

NCT04577495

Conditions: Computed Tomography, Hemic and Lymphatic Diseases, Histology, +10 more
Locations: Not specified

View Trial Details

Completed

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

NCT00024076

Conditions: Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +28 more
Locations: Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

View Trial Details

Completed

The Role of the Thymus in Myasthenia Gravis

NCT01102192

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Hemic and Lymphatic Diseases, +17 more
Locations: Charite University (Dept of Neurology & NeuroCure Clinical Research Center NCRC) Berlin, Germany

View Trial Details

Completed

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

NCT00066404

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +114 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies

NCT00921739

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer

NCT00372840

Conditions: Adenoma, Breast Cancer, Breast Diseases, +49 more
Locations: Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Chemoradiotherapy for Limited Advanced Unresectable Thymic Epithelial Tumors

NCT02636556

Conditions: Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +7 more
Locations: Kailiang Wu Shanghai, Shanghai Municipality, China

View Trial Details